Literature DB >> 14657486

Cell migration: integrating signals from front to back.

Anne J Ridley1, Martin A Schwartz, Keith Burridge, Richard A Firtel, Mark H Ginsberg, Gary Borisy, J Thomas Parsons, Alan Rick Horwitz.   

Abstract

Cell migration is a highly integrated multistep process that orchestrates embryonic morphogenesis; contributes to tissue repair and regeneration; and drives disease progression in cancer, mental retardation, atherosclerosis, and arthritis. The migrating cell is highly polarized with complex regulatory pathways that spatially and temporally integrate its component processes. This review describes the mechanisms underlying the major steps of migration and the signaling pathways that regulate them, and outlines recent advances investigating the nature of polarity in migrating cells and the pathways that establish it.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657486     DOI: 10.1126/science.1092053

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  1851 in total

Review 1.  Syntrophins entangled in cytoskeletal meshwork: Helping to hold it all together.

Authors:  Sahar S Bhat; Roshia Ali; Firdous A Khanday
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

Review 2.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology.

Authors:  Nobuyoshi Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-06       Impact factor: 3.402

3.  Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells.

Authors:  Chuu-Yun A Wong; Hada Wuriyanghan; Yan Xie; Ming-Fong Lin; Peter W Abel; Yaping Tu
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

4.  Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected].

Authors:  Yingchun Wang; Jonathan A Kelber; Hop S Tran Cao; Greg T Cantin; Rui Lin; Wei Wang; Sharmeela Kaushal; Jeanne M Bristow; Thomas S Edgington; Robert M Hoffman; Michael Bouvet; John R Yates; Richard L Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

5.  MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2.

Authors:  Jia Yu; Han Peng; Qing Ruan; Anees Fatima; Spiro Getsios; Robert M Lavker
Journal:  FASEB J       Date:  2010-06-07       Impact factor: 5.191

6.  Paxillin dynamics measured during adhesion assembly and disassembly by correlation spectroscopy.

Authors:  Michelle A Digman; Claire M Brown; Alan R Horwitz; William W Mantulin; Enrico Gratton
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

7.  Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration.

Authors:  Simona Donatello; Irina S Babina; Lee D Hazelwood; Arnold D K Hill; Ivan R Nabi; Ann M Hopkins
Journal:  Am J Pathol       Date:  2012-09-29       Impact factor: 4.307

8.  Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.

Authors:  Christine T Brew; Ida Aronchik; Karena Kosco; Jasmine McCammon; Leonard F Bjeldanes; Gary L Firestone
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

9.  Biochemical evidence of the interactions of membrane type-1 matrix metalloproteinase (MT1-MMP) with adenine nucleotide translocator (ANT): potential implications linking proteolysis with energy metabolism in cancer cells.

Authors:  Ilian A Radichev; Albert G Remacle; Nor Eddine Sounni; Sergey A Shiryaev; Dmitri V Rozanov; Wenhong Zhu; Natalya V Golubkova; Tatiana I Postnova; Vladislav S Golubkov; Alex Y Strongin
Journal:  Biochem J       Date:  2009-04-28       Impact factor: 3.857

10.  Adenosine arrests breast cancer cell motility by A3 receptor stimulation.

Authors:  Carola Ledderose; Marco M Hefti; Yu Chen; Yi Bao; Thomas Seier; Linglin Li; Tobias Woehrle; Jingping Zhang; Wolfgang G Junger
Journal:  Purinergic Signal       Date:  2016-08-30       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.